Ask AI
H.R. 5239

Prescription Drug Price Reporting Act

Prescription Drug Price Reporting Act

This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.

HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.

Referred to the Subcommittee on Health.

Rep. Joyce, David P. [R-OH-14](R-OH)Sponsor
1 cosponsor1 R
1cosponsors1committees4actions1related bills8subjects
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

Prescription Drug Price Reporting Act — Informed